CXCL10 and lung carcinoma: Moreover, non-CD8+ PBMCs, containing NKs, macrophages, DCs, and CD4+ T cells, exhibited lower A549-stimulated CXCL10 expression in a patient with lung cancer compared to a healthy volunteer after co-cultured with A549 for 24 h (Fig. 5F).